Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.


CSE:BUX - Post by User

Post by geodcanon Feb 27, 2023 4:54pm
164 Views
Post# 35308170

dyodd

dyoddHit the insider tab on the info banner at the top of the page and check it out for yerself!

I think it would be fair to say that insiders Bux and Huang are keeping the shareprice up for a long time.

The spike up, it seems was pretty much orchestrated by their trades and the continual support of this .20c range for the last little while.

All of that being said, I do have a bid in for 200k shares on the hope that this new tech testing that they are working on could be a gamechanger and if they can get shareholders back to buying mode.

Some positive development and more acknowledement from peers and such.

The fact that we can still raise some funding for development from certified agencies bodes well.

If they can turn this into a run-away winner and successful new technique, shareholders could go along for the ride but not just with their shareprice supports.

glta and dyodd
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities